Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.
Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095–105.
Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.
Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345–57.
Joseph DA, King JB, Miller JW, et al. Prevalence of colorectal cancer screening among adults-Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Suppl. 2012;61:51–6.
USPST Force,Bibbins-Domingo K,Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564–75.
White A, Thompson TD, White MC, et al. Cancer screening test use - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:201–6.
Halm EA, Beaber EF, McLerran D, et al. Association between primary care visits and colorectal cancer screening outcomes in the era of population health outreach. J Gen Intern Med. 2016;31:1190–7.
Levin TR, Jamieson L, Burley DA, et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33:101–10.
Mehta SJ, Jensen CD, Quinn VP, et al. Race/ethnicity and adoption of a population health management approach to colorectal cancer screening in a community-based healthcare system. J Gen Intern Med. 2016;31:1323–30.
Green BB, Wang C, Anderson ML, et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013;158:301–11.
Sequist TD, Zaslavsky AM, Colditz GA, et al. Electronic patient messages to promote colorectal cancer screening: a randomized, controlled trial. Arch Intern Med. 2011;171:636–41.
Charters TJ, Strumpf EC, Sewitch MJ. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians. BMC Health Serv Res. 2013;13:449.
Klabunde C, Blom J, Bulliard J-L, et al. Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen. 2015;22:119–26.
Daly JM, Levy BT, Merchant ML, et al. Mailed fecal-immunochemical test for colon cancer screening. J Community Health. 2010;35:235–9.
Wilson FA, Villarreal R, Stimpson JP, et al. Cost-effectiveness analysis of a colonoscopy screening navigator program designed for Hispanic men. J Cancer Educ. 2015;30:260–7.
Elkin EB, Shapiro E, Snow JG, et al. The economic impact of a patient navigator program to increase screening colonoscopy. Cancer. 2012;118:5982–8.
Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173:1725–32.
Singal AG, Gupta S, Skinner CS, et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial. JAMA. 2017;318:806–15.
Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211:453–8.
Mehta SJ, Asch DA. How to help gastroenterology patients help themselves: leveraging insights from behavioral economics. Clin Gastroenterol Hepatol. 2014;12:711–4.
Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47:263–91.
Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298:2415–7.
O’Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89:103–24.
Samuelson W, Zeckhauser R. Status quo bias in decision making. J Risk Uncertain. 1988;1:7–59.
Halpern SD, Ubel PA, Asch DA. Harnessing the power of default options to improve health care. New Engl J Med. 2007;357:1340–4.
Chapman GB, Li M, Colby H, et al. Opting in vs opting out of influenza vaccination. JAMA. 2010;304:43–44.
Johnson EJ, Goldstein D. Do defaults save lives? Science. 2003;302:1338–9.
Mehta SJ, Troxel AB, Marcus N, et al. Participation rates with opt-out enrollment in a remote monitoring intervention for patients with myocardial infarction. JAMA Cardiol. 2016;1:847–8.
Yudin MH, Moravac C, Shah RR. Influence of an “opt-out” test strategy and patient factors on human immunodeficiency virus screening in pregnancy. Obstet Gynecol. 2007;110:81–6.
Aysola J, Tahirovic E, Troxel AB, et al. A randomized controlled trial of opt-in versus opt-out enrollment into a diabetes behavioral intervention. Am J Health Promot. 2016;32:745–52.
Schwartz J, Mochon D, Wyper L, et al. Healthier by precommitment. Psychol Sci. 2014;25:538–46.
Milkman KL, Beshears J, Choi JJ, et al. Using implementation intentions prompts to enhance influenza vaccination rates. Proc Natl Acad Sci USA. 2011;108:10415–20.
Asch DA, Ziolek TA, Mehta SJ. Misdirections in informed consent - impediments to health care innovation. N Engl J Med. 2017;377:1412–4.
U.S. Census Bureau. Social Explorer [database online]. Social Explorer, Bronxville, NY. 2015. https://www.socialexplorer.com/tables/ACS2015_5yr/R11471487. Accessed 28 Sep 2017.
Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110:2083–91.
Charlton ME, Mengeling MA, Halfdanarson TR, et al. Evaluation of a home-based colorectal cancer screening intervention in a rural state. J Rural Health. 2014;30:322–32.
Myers RE, Ross EA, Wolf TA, et al. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care. 1991;29:1039–50.
Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96:770–80.
Goldman SN, Liss DT, Brown T, et al. Comparative effectiveness of multifaceted outreach to initiate colorectal cancer screening in community health centers: a randomized controlled trial. J Gen Intern Med. 2015;30:1178–84.
Mehta SJ, Feingold J, Vandertuyn M, et al. Active choice and financial incentives to increase rates of screening colonoscopy: a randomized controlled trial. Gastroenterology. 2017;153:1227–9.
Narula T, Ramprasad C, Ruggs EN, et al. Increasing colonoscopies? A psychological perspective on opting in versus opting out. Health Psychol. 2014;33:1426–9.
van Roon AH, Hol L, Wilschut JA, et al. Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial. Prev Med. 2011;52:448–51.
Cole SR, Smith A, Wilson C, et al. An advance notification letter increases participation in colorectal cancer screening. J Med Screen. 2007;14:73–75.
Fehr E,Gachter S, Fairness and retaliation: the economics of reciprocity. J Econ Perspect. 2000;14:159–81.
Kahneman D, Knetsch JL, Thaler RH. Experimental tests of the endowment effect and the Coase theorem. J Political Econ. 1990;98:1325–48.
Keller PA, Harlam B, Loewenstein G, et al. Enhanced active choice: a new method to motivate behavior change. J Consum Psychol. 2011;21:376–83.
Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33:88–100.
Lairson DR, Dicarlo M, Deshmuk AA, et al. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care. Cancer. 2014;120:1042–9.
Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–82.